{"id":1438,"date":"2018-10-08T13:15:42","date_gmt":"2018-10-08T11:15:42","guid":{"rendered":"http:\/\/semmelweis.hu\/laboratorium\/?page_id=1438"},"modified":"2026-03-24T07:02:37","modified_gmt":"2026-03-24T06:02:37","slug":"tomegspektrometriai-reszleg","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/laboratorium\/reszlegek\/tomegspektrometriai-reszleg\/","title":{"rendered":"T\u00f6megspektrometriai \u00e9s Elv\u00e1laszt\u00e1stechnikai Laborat\u00f3rium"},"content":{"rendered":"
\n

H\u00edrek, esem\u00e9nyek<\/h2>\n
\n\n
\n

V\u00e9szforga<\/strong>t\u00f3k\u00f6nyv labordiagnosztikai szolg\u00e1ltat\u00e1s le\u00e1ll\u00e1sa eset\u00e9re<\/strong><\/a><\/p>\n<\/div>\n

\n
\u00daj vizsg\u00e1latok bevezet\u00e9se<\/strong><\/div>\n
2026 febru\u00e1r 1-t\u0151l<\/strong> az antikonvulz\u00edv gy\u00f3gyszerek ter\u00e1pi\u00e1s monitoroz\u00e1s\u00e1t a Semmelweis Egyetem Laborat\u00f3riumi Medicina Int\u00e9zetben az Amerikai \u00fati K\u00f6zponti Laborat\u00f3rium (Idegseb\u00e9szeti \u00e9s Neurointervenci\u00f3s Klinika) v\u00e9gzi. A T\u00f6megspektrometriai \u00e9s Elv\u00e1laszt\u00e1stechnikai Laborat\u00f3riumt\u00f3l ezek a vizsg\u00e1latok nem lesznek k\u00e9rhet\u0151k.<\/span><\/div>\n

Az \u00e9rintett vizsg\u00e1latok: fenitoin, karbamazepin \u00e9s karbamazepin-epoxid, lamotrigine, levetiracetam.<\/p>\n

A vizsg\u00e1lattal kapcsolatos inform\u00e1ci\u00f3k az Int\u00e9zet vizsg\u00e1lati regiszter\u00e9ben (https:\/\/semmelweis.hu\/laboratorium\/vizsgalati-regiszter\/) \u00e9s a K\u00f6zponti Laborat\u00f3rium (Idegseb\u00e9szeti \u00e9s Neurointervenci\u00f3s Klinika) honlapj\u00e1n (https:\/\/semmelweis.hu\/laboratorium\/reszlegek\/kozponti-laboratorium-idegsebeszeti-es-neurointervencios-klinika\/<\/a>) lesznek megtal\u00e1lhat\u00f3k.<\/p>\n

\n

A K\u00f6zponti Laborat\u00f3rium (Idegseb\u00e9szeti \u00e9s Neurointervenci\u00f3s Klinika) el\u00e9rhet\u0151s\u00e9gei:<\/p>\n

C\u00edm:<\/strong> 1145 Budapest, Laky Adolf utca 44-46. Diagnosztikai \u00e9p\u00fclet 3. emelet.<\/p>\n

Laborat\u00f3rium vezet\u0151:<\/strong> G\u00e1l Anna<\/p>\n

Email:<\/strong> labor.amerikaiut@semmelweis.hu<\/p>\n

Telefonsz\u00e1m: <\/strong>+36-1-4679-347<\/p>\n<\/div>\n

2025. november 1-t\u0151l a Laborat\u00f3riumi Medicina Int\u00e9zet \u00e1ltal, ter\u00e1pi\u00e1s gy\u00f3gyszerszint monitoroz\u00e1s keret\u00e9ben v\u00e9gzett vizsg\u00e1latok k\u00edn\u00e1lata a hidroxiklorokinnal\u00a0<\/strong>b\u0151v\u00fclt. A vizsg\u00e1lt param\u00e9terek: hidroxiklorokin, dezetil-hidroxiklorokin<\/strong>. A vizsg\u00e1latot EDTA-val alvad\u00e1sg\u00e1tolt v\u00e9rb\u0151l v\u00e9gezz\u00fck, a mintaig\u00e9ny 1 cs\u0151 teljes v\u00e9r. A vizsg\u00e1lat n\u00e9met pont\u00e9rt\u00e9ke 4472, a lelet\u00e1tfordul\u00e1si id\u0151 legfeljebb 1 h\u00e9t. A vizsg\u00e1latok a\u00a0NETLLCMS\u00a0<\/strong>k\u00e9r\u0151lapon k\u00e9rhet\u0151k. A Semmelweis Egyetemen k\u00edv\u00fclr\u0151l t\u00f6rt\u00e9n\u0151 vizsg\u00e1latk\u00e9r\u00e9shez k\u00e9rj\u00fck, hogy a https:\/\/semmelweis.hu\/laboratorium\/vizsgalati-regiszter\/<\/strong><\/a> oldalon, a \u201eVIZSG\u00c1LATK\u00c9R\u0150K\u201d f\u00fcl\u00f6n megtal\u00e1lhat\u00f3 vizsg\u00e1latk\u00e9r\u0151 lapot (Vizsg\u00e1latk\u00e9r\u0151 lap-Egy\u00e9b gy\u00f3gyszerek) sz\u00edveskedjenek haszn\u00e1lni.<\/p>\n

\n

K\u00e9rj\u00fck a vizsg\u00e1lati mint\u00e1kat az al\u00e1bbi mintav\u00e9teli pontok egyik\u00e9re eljuttatni:<\/strong><\/p>\n

SE LMI K\u00f6zponti Laborat\u00f3rium, K\u00fcls\u0151 Klinikai T\u00f6mb, \u2018B\u2019 \u00e9p\u00fclet 1. emelet (1082 Budapest, \u00dcll\u0151i \u00fat 78\/A),<\/p>\n

SE LMI Klinikai Genetikai \u00e9s Endokrinol\u00f3giai Laborat\u00f3rium, Nagyv\u00e1rad t\u00e9ri Elm\u00e9leti T\u00f6mb (1089 Budapest, Nagyv\u00e1rad t\u00e9r 4. 16. emelet).<\/p>\n<\/div>\n\n<\/div>

Vizsg\u00e1latok<\/h2>\n
\n\n
\n

Ter\u00e1pi\u00e1s gy\u00f3gyszerszint monitoroz\u00e1s keret\u00e9ben v\u00e9gzett vizsg\u00e1latok adatai<\/span><\/a><\/p>\n<\/div>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Vizsg\u00e1lat neve<\/th>OENO K\u00f3d<\/th>Pont<\/th>Minta<\/th>Eredm\u00e9ny<\/th>K\u00e9r\u00f5lap (MEDSOL)<\/th>\n<\/tr>\n<\/thead>\n
3-metoxi-tiramin plazm\u00e1ban LC-MS\/MS-sel, az egyetem klinik\u00e1i sz\u00e1m\u00e1ra (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24426<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
3-metoxi-tiramin plazm\u00e1ban LC-MS\/MS-sel, szerz\u00f5d\u00f6tt k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>4430 HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
3-metoxi-tiramin plazm\u00e1ban LC-MS\/MS-sel, szerz\u00f5d\u00f6tt, nem k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>6040 HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
3-metoxi-tiramin plazm\u00e1ban LC-MS\/MS-sel, mag\u00e1nszem\u00e9lyek r\u00e9sz\u00e9re (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>6710 HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
3-metoxi-tiramin vizeletben HPLC-vel, az egyetem klinik\u00e1i sz\u00e1m\u00e1ra (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24426<\/td>2236<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
3-metoxi-tiramin vizeletben HPLC-vel, szerz\u00f5d\u00f6tt k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>4430 HUF<\/td><\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
3-metoxi-tiramin vizeletben HPLC-vel, szerz\u00f5d\u00f6tt, nem k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>6040 HUF<\/td><\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
3-metoxi-tiramin vizeletben HPLC-vel, mag\u00e1nszem\u00e9lyek r\u00e9sz\u00e9re (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>6710 HUF<\/td><\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
5-hidroxiindolecetsav vizeletben HPLC-vel<\/td>24492<\/td>1699<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
17-hidroxi-progeszteron LC-MS\/MS-sel<\/td>24351<\/td>680<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLSTER<\/td>\n<\/tr>\n
17-hidroxi-progeszteron LC-MS\/MS-sel, 60 perces terhel\u00e9s ut\u00e1n<\/td>24351<\/td>680<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLST60<\/td>\n<\/tr>\n
Adrenalin vizeletben HPLC-vel (vizelet katekolamin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)
\n<\/td>		24429<\/td>894<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Alpelizib plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Amiszulprid sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Ampicillin sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Androsztendion LC-MS\/MS-sel<\/td>24190<\/td>2254<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLSTER<\/td>\n<\/tr>\n
Androsztendion LC-MS\/MS-sel, 60 perces terhel\u00e9s ut\u00e1n<\/td>24190<\/td>2254<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLST60<\/td>\n<\/tr>\n
Apixaban sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLLCMS<\/td>\n<\/tr>\n
Aripiprazol \u00e9s dehidro-aripiprazol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
A vitamin sz\u00e9rumban HPLC-vel<\/td>21609<\/td>3650<\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLVIT<\/td>\n<\/tr>\n
E vitamin sz\u00e9rumban HPLC-vel, SE bek\u00fcld\u00f5k eset\u00e9n<\/td>8000 HUF<\/td><\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLVIT<\/td>\n<\/tr>\n
E vitamin sz\u00e9rumban HPLC-vel, Egyetemen k\u00edv\u00fcli bek\u00fcld\u00f5k eset\u00e9n \u00e9s mag\u00e1nszem\u00e9lyek r\u00e9sz\u00e9re<\/td>11000 HUF<\/td><\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLVIT<\/td>\n<\/tr>\n
Cefazolin sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Cefepim sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Ceftazidim sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Ceftriaxon sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Colistin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Klozapin \u00e9s norklozapin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Kortizol vizeletben LC-MS\/MS-sel<\/td>24220<\/td>1041<\/td>24 \u00f3r\u00e1s gy\u00fbjt\u00f6tt vizelet<\/td>7 nap<\/td>NETLSTER<\/td>\n<\/tr>\n
Dabrafenib plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Dehidro-epiandroszteron LC-MS\/MS-sel<\/td>24395<\/td>894<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLSTER<\/td>\n<\/tr>\n
Dehidro-epiandroszteron LC-MS\/MS-sel, 60 perces terhel\u00e9s ut\u00e1n<\/td>24395<\/td>894<\/td>Nat\u00edv v\u00e9r<\/td>14 nap<\/td>NETLST60<\/td>\n<\/tr>\n
Dopamin vizeletben HPLC-vel (vizelet katekolamin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>2442B<\/td>894<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Eszcitalopram sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Flupentixol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Fluvoxamin LC-MS\/MS-sel
\n<\/td>		21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Haloperidol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Hidroxiklorokin \u00e9s dezetil-hidroxiklorokin teljes v\u00e9rben LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>EDTA-s v\u00e9r<\/td>7 nap<\/td>NETLLCMS<\/td>\n<\/tr>\n
Homovanillinsav vizeletben HPLC-vel<\/td>24428<\/td>2281<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Kariprazin \u00e9s akt\u00edv metabolitjai sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>6708<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Klonazep\u00e1m sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Kvetiapin \u00e9s norkvetiapin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Linezolid sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Meropenem sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Metanefrin plazm\u00e1ban LC-MS\/MS-sel (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24425<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
Metanefrin vizeletben HPLC-vel (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24425<\/td>2236<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Noradrenalin vizeletben HPLC-vel (vizelet katekolamin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>2442A<\/td>894<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Normetanefrin plazm\u00e1ban LC-MS\/MS-sel (plazma metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24426<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>14 nap<\/td>NETLPL<\/td>\n<\/tr>\n
Normetanefrin vizeletben HPLC-vel (vizelet metanefrin panel r\u00e9szek\u00e9nt k\u00e9rhet\u00f5)<\/td>24426<\/td>2236<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Olanzapin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Oxiszterolok plazm\u00e1ban LC-MS\/MS-sel, az egyetem klinik\u00e1i sz\u00e1m\u00e1ra<\/td>24491<\/td>2684<\/td>EDTA-s v\u00e9r<\/td>30 nap<\/td>NETLOXY<\/td>\n<\/tr>\n
Oxiszterolok plazm\u00e1ban LC-MS\/MS-sel, szerz\u00f5d\u00f6tt k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re<\/td>5315 HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>30 nap<\/td>NETLOXY<\/td>\n<\/tr>\n
Oxiszterolok plazm\u00e1ban LC-MS\/MS-sel, szerz\u00f5d\u00f6tt, nem k\u00f6zszolg\u00e1ltat\u00f3 partnerek r\u00e9sz\u00e9re<\/td>7250HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>30 nap<\/td>NETLOXY<\/td>\n<\/tr>\n
Oxiszterolok plazm\u00e1ban LC-MS\/MS-sel, mag\u00e1nszem\u00e9lyek r\u00e9sz\u00e9re<\/td>8050 HUF<\/td><\/td>EDTA-s v\u00e9r<\/td>30 nap<\/td>NETLOXY<\/td>\n<\/tr>\n
Palbociklib plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td><\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Paliperidon sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Paroxetin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Piperacillin sz\u00e9rumban HPLC-vel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAB<\/td>\n<\/tr>\n
Pozakonazol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAZOL<\/td>\n<\/tr>\n
Risperidon \u00e9s paliperidon sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Rivaroxaban sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLLCMS<\/td>\n<\/tr>\n
Szelumetinib plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Szertralin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Szteroid profil vizsg\u00e1lat LC-MS\/MS-sel, androg\u00e9n vonal (7 param\u00e9ter)<\/td>7 param\u00e9ter ker\u00fcl elsz\u00e1mol\u00e1sra.<\/td>7045<\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLPAST<\/td>\n<\/tr>\n
Szteroid profil vizsg\u00e1lat LC-MS\/MS-sel (16 param\u00e9ter)<\/td>16 param\u00e9ter ker\u00fcl elsz\u00e1mol\u00e1sra.<\/td>16102<\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLPAST<\/td>\n<\/tr>\n
Szteroid profil vizsg\u00e1lat LC-MS\/MS-sel, androg\u00e9n vonal, 60 perces terhel\u00e9s ut\u00e1n (7 param\u00e9ter)<\/td>7 param\u00e9ter ker\u00fcl elsz\u00e1mol\u00e1sra.<\/td>7045<\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLPA60<\/td>\n<\/tr>\n
Szteroid profil vizsg\u00e1lat LC-MS\/MS-sel, 60 perces terhel\u00e9s ut\u00e1n (16 param\u00e9ter)<\/td>16 param\u00e9ter ker\u00fcl elsz\u00e1mol\u00e1sra.<\/td>16102<\/td>Nat\u00edv v\u00e9r<\/td>30 nap<\/td>NETLPA60<\/td>\n<\/tr>\n
Tazemetostat plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Teriflunomide plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Trametinib plazm\u00e1ban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>EDTA-s v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Vanilmandulasav vizeletben HPLC-vel<\/td>24427<\/td>2281<\/td>24 \u00f3r\u00e1s, savra gy\u00fbjt\u00f6tt vizelet<\/td>14 nap<\/td>NETLBIOA<\/td>\n<\/tr>\n
Venetoklax sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLONCO<\/td>\n<\/tr>\n
Venlafaxin \u00e9s O-dezmetil-venlafaxin sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>4472<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n
Vorikonazol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLAZOL<\/td>\n<\/tr>\n
Zuklopentixol sz\u00e9rumban LC-MS\/MS-sel<\/td>21646<\/td>2236<\/td>Nat\u00edv v\u00e9r<\/td>3 nap<\/td>NETLPSY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n<\/div>

Mintakezel\u00e9s<\/h2>\n
\n\n
A k\u00f6vetkez\u0151 le\u00edr\u00e1sokkal a laborat\u00f3riumunkba k\u00fcldend\u0151 mint\u00e1k kezel\u00e9s\u00e9hez szeretn\u00e9nk hasznos \u00fatmutat\u00e1st adni:<\/div>\n